Skip to content
  • Sunday, 26 July 2026
  • 2:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children
Pharmaceutical R&D

UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children

Teuku Ryan Jun 15, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…

Read More
Pharmaceutical R&D

Sanofi Receives FDA Approval to Expand Tzield Use in Children as Young as One Year for Type 1 Diabetes Delay

Teuku Ryan Apr 23, 2026 0

Sanofi has secured a significant expansion of its U.S. Food and Drug Administration (FDA) approval for Tzield (teplizumab-mzwv), a groundbreaking…

Read More
Neuroscience & Brain Research

Collaborative Study Links Cellular Energy Disruption to Early-Stage Major Depressive Disorder in Young Adults

Rifan Muazin Apr 1, 2026 0

A groundbreaking international collaboration between the University of Queensland and the University of Minnesota has unveiled a significant biological breakthrough…

Read More
Neuroscience & Brain Research

Collaborative Research Links Mitochondrial Dysfunction and ATP Imbalance to Early-Stage Major Depressive Disorder in Young Adults

Rifan Muazin Mar 22, 2026 0

In a landmark international collaboration, researchers from the University of Queensland and the University of Minnesota have unveiled a significant…

Read More
A New Raptor Species, Kank australis, Unveiled in Patagonia, Reveals Ancient Fish-Hunting LifestyleThe Human Body is Far From Fully Mapped: New Discoveries Challenge Centuries of Anatomical UnderstandingUK and Switzerland Forge Landmark Free Trade Agreement, Cementing Pharmaceutical Intellectual Property ProtectionsThe Hidden Dynamics of Cosmic Voids and the Role of Quantum Vacuum Energy in Universal Expansion
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ